Proactiveinvestors Australia

Alexium International Group alexiuminternational.com/

Alexium International Group (ASX: AJX) was founded to commercialise a reactive surface treatment process originally developed by the U.S. Air Force. The company acquired the technology from the U.S. Department of Defense to produce solutions for commercial and military customers.

Tweet

 

Email

Email to a friend:

To:

Separate multiple addresses with commas.

From Email address:

Name: Please send me a copy Message:

Verification code

Enter the code from aboveRequired

Send

Alexium International Group strengthens leadership as it begins commercial licensing phase

Alexium International Group (ASX: AJX, AX: AJX, OTC QX: AXXIY) has undergone a board and leadership restructure as it moves into the commercial licensing phase of its patented reactive surface technology.

Non-executive chairman Gavin Rezos will move into the new role of executive chairman and president.

Rezos will spend more time in the U.S. and Europe overseeing the operational and commercial parts of the business and Alexium’s network overseas.

Alexium is using its RST technology – a "green" process that can apply durable nanoscopic polymeric coatings to numerous materials – to develop a fire retardant nylon treatment.

The company is accelerating commercial licensing with larger demonstration runs of the technology.

Alexium’s fire retardant nylon treatment could generate high profit margins for the company with strong demand from the U.S. military and commercial customers in the U.S. and overseas.

The company is aiming to address demand from the U.S. military, which currently has 1.4 million soldiers serving on active duty and 800,000 soldiers on reserve duty, as well as commercial customers in the U.S. and abroad.

Alexium anticipates a combined market demand of at least 4 million linear yards per year.

New leadership team

The U.S. team comprises:

- Executive director Stefan Susta – responsible for U.S. operations, defence business, commercial partnerships and U.S. commercial business development; and
- Chief scientific officer Bob Brookins – responsible for product development and support, intellectual property and the Co-Operative Research and Development Agreement with the U.S. Air Force.

The Australia team includes:

- Executive chairman Gavin Rezos – responsible for the overall running of the business in its entirety; and
- Chief financial officer and company secretary Nicholas Clark – responsible for Alexium’s financial and administrative requirements, as well as regulatory requirements and investor relations.
Finally, in Europe, Alexium is represented by manager business development Europe John Almond who is responsible for the continuous sourcing of business opportunities in the region.

Sign up to Proactive Investors

Comments from Proactive Investors readers

• Fill in your details below:

Verification Code

Reload image